As of 2025-09-19, the Relative Valuation of Chinook Therapeutics Inc (KDNY) is (46.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 40.39 USD, the upside of Chinook Therapeutics Inc based on Relative Valuation is -215.8%.
The range of the Relative Valuation is (45.84) - (47.62) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 14.0x | 13.7x |
| Forward P/E multiples | 13.4x - 13.9x | 13.6x |
| Fair Price | (45.84) - (47.62) | (46.78) |
| Upside | -213.5% - -217.9% | -215.8% |
| Date | P/E |